Correction: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial

Chevret, Sylvie; Bouadma, Lila; Dupuis, Claire; Burdet, Charles; Timsit, Jean‑Francois

doi:10.1186/s13613-023-01194-x

Annals of Intensive Care

Article metrics
Last updated: Thu, 9 May 2024 6:46:17 Z

Correction: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial

Access & Citations

689

Article Accesses
0

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.